Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome
Clinical trial NCT00269412 · COMPLETED
Trial details
- NCT number
- NCT00269412
- Sponsor
- Bausch Health Americas, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2007-08-01
- Enrollment
- 525
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.